Pfiz­er sets Paxlovid price at $1,390 for five-day course

Pfiz­er will charge $1,390 for a five-day course of Paxlovid on the com­mer­cial mar­ket, in­creas­ing the price from the pan­dem­ic-era rate it had been giv­ing to the US gov­ern­ment.

The drug­mak­er last week an­nounced the end of a pro­gram where US health au­thor­i­ties bought and were re­spon­si­ble for dis­trib­ut­ing the Paxlovid dos­es at a price of $530 per course. Many of those pills, cleared un­der emer­gency use au­tho­riza­tion, will be re­turned to the drug­mak­er. Be­cause of that, and be­cause of de­clin­ing de­mand for Covid prod­ucts over­all, Pfiz­er is em­bark­ing on a $3.5 bil­lion cost-cut­ting pro­gram this year and next.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER